Ventus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ventus Therapeutics's estimated annual revenue is currently $17.5M per year.
- Ventus Therapeutics's estimated revenue per employee is $155,000
- Ventus Therapeutics's total funding is $300M.
Employee Data
- Ventus Therapeutics has 113 Employees.
- Ventus Therapeutics grew their employee count by 11% last year.
Ventus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $25.9M | 181 | 3% | $150.5M | N/A |
#2 | $28.4M | 183 | -56% | N/A | N/A |
#3 | $4.3M | 28 | 8% | N/A | N/A |
#4 | $55.6M | 359 | 1% | N/A | N/A |
#5 | $11M | 71 | 20% | N/A | N/A |
#6 | $22.2M | 143 | -22% | N/A | N/A |
#7 | $4.2M | 27 | 13% | N/A | N/A |
#8 | $2M | 13 | 0% | N/A | N/A |
#9 | $295.7M | 1908 | 5% | N/A | N/A |
#10 | $2.8M | 18 | 6% | N/A | N/A |
What Is Ventus Therapeutics?
Ventus is a newly established venture-backed biotech company pursuing small molecule therapeutics targeting key innate immune pathways for numerous auto-immune and auto-inflammatory diseases. Ventus was founded by world leaders in structural immunology and innate immunity who discovered that innate immune signaling leads to the formation of multimeric complexes that drive the subsequent inflammatory cascade. Leveraging the expertise of our founders, Ventus is the only company capable of pursuing biochemical and structure-based drug discovery for highly sought-after targets of these multimeric complexes.
keywords:N/A
$300M
Total Funding
113
Number of Employees
$17.5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ventus Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Scientist | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Executive Director, Discovery Biology | Reveal Email/Phone |
4 | Director | Reveal Email/Phone |
5 | Senior Director, Head Regulatory Affairs | Reveal Email/Phone |
6 | Director Chemistry | Reveal Email/Phone |
7 | Head Clinical Operations | Reveal Email/Phone |
8 | Principal Investigator | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Senior Director Business Operations | Reveal Email/Phone |
Ventus Therapeutics News
Boeing Global Services, Express, Sierra Space, OppFi, Lumen Technologies, CKE Restaurants, Milestone, M2GEN, Ventus Therapeutics, AnyRoad.
Ventus Therapeutics is a biopharmaceutical company utilizing structural biology and computational tools to identify and develop small molecule...
Ventus Therapeutics, Inc., a biotechnology company utilizing rational structure-based drug design to discover small-molecule medicines for high value and elusive targets, today announced a $100 million Series B financing led by RA Capital Management with participation from a select syndicate inc ...
Ventus Therapeutics, Inc., a Boston, Massachusetts and Montreal, Canada-based biotechnology company utilizing rational structure-based drug design to discover small-molecule medicines for high value and elusive targets, raised $100m in Series B financing. The round was led by RA Capital Managem ...
WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics Inc. today announced a $60 million Series A financing led by founding investor Versant Ventures with participation by GV (formerly Google Ventures). Proceeds will be used to advance three pipeline programs and to expand the company’ ...
Other Companies in Montreal
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.4M | 113 | 2% | N/A |
#2 | $34.5M | 113 | -2% | N/A |
#3 | $16.4M | 113 | -16% | N/A |
#4 | $15.8M | 113 | 55% | N/A |
#5 | $22.8M | 113 | 22% | N/A |